Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine
$ 20.99 · 4.7 (285) · In stock
News From Nicholas Hall & Company, Nicholas Hall Company Blog
Drug-Induced Disorders of the Nervous System
Drug Office - Other safety alerts
Cerebrovascular Dysregulation: Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.
Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions - ScienceDirect
Sci. Pharm., Free Full-Text
Frontiers Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size
Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome as Syndromes of Cerebrovascular Dysregulation
Posterior reversible encephalopathy syndrome: A review with emphasis on neuroimaging characteristics - ScienceDirect